These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 28770670)
1. Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease. Son HJ; Han SH; Lee JA; Shin EJ; Hwang O Free Radic Res; 2017 Jun; 51(6):633-645. PubMed ID: 28770670 [TBL] [Abstract][Full Text] [Related]
2. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models. Lee JA; Son HJ; Park KD; Han SH; Shin N; Kim JH; Kim HR; Kim DJ; Hwang O Neurotox Res; 2015 Nov; 28(4):332-45. PubMed ID: 26233727 [TBL] [Abstract][Full Text] [Related]
3. A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model. Lee JA; Kim JH; Woo SY; Son HJ; Han SH; Jang BK; Choi JW; Kim DJ; Park KD; Hwang O Br J Pharmacol; 2015 Feb; 172(4):1087-100. PubMed ID: 25297649 [TBL] [Abstract][Full Text] [Related]
4. Lutein suppresses inflammatory responses through Nrf2 activation and NF-κB inactivation in lipopolysaccharide-stimulated BV-2 microglia. Wu W; Li Y; Wu Y; Zhang Y; Wang Z; Liu X Mol Nutr Food Res; 2015 Sep; 59(9):1663-73. PubMed ID: 26016441 [TBL] [Abstract][Full Text] [Related]
5. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease. Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429 [TBL] [Abstract][Full Text] [Related]
7. Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease. Kim SS; Lim J; Bang Y; Gal J; Lee SU; Cho YC; Yoon G; Kang BY; Cheon SH; Choi HJ J Nutr Biochem; 2012 Oct; 23(10):1314-23. PubMed ID: 22227268 [TBL] [Abstract][Full Text] [Related]
8. FTY720 Inhibits MPP Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia. Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539 [TBL] [Abstract][Full Text] [Related]
10. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Jazwa A; Rojo AI; Innamorato NG; Hesse M; Fernández-Ruiz J; Cuadrado A Antioxid Redox Signal; 2011 Jun; 14(12):2347-60. PubMed ID: 21254817 [TBL] [Abstract][Full Text] [Related]
12. 2-Acetyl-7-hydroxy-6-methoxy-1-methyl-1,2,3,4,-tetrahydroisoquinoline exhibits anti-inflammatory properties and protects the nigral dopaminergic neurons. Son HJ; Han SH; Lee JA; Lee CS; Seo JW; Chi DY; Hwang O Eur J Pharmacol; 2016 Jan; 771():152-61. PubMed ID: 26687634 [TBL] [Abstract][Full Text] [Related]
13. Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220. Lee JA; Son HJ; Choi JW; Kim J; Han SH; Shin N; Kim JH; Kim SJ; Heo JY; Kim DJ; Park KD; Hwang O Neurochem Int; 2018 Jan; 112():96-107. PubMed ID: 29158022 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model. Qiu X; Wang Q; Hou L; Zhang C; Wang Q; Zhao X Toxicol Lett; 2021 Oct; 349():1-11. PubMed ID: 34052309 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells. Parga JA; Rodriguez-Perez AI; Garcia-Garrote M; Rodriguez-Pallares J; Labandeira-Garcia JL Free Radic Biol Med; 2018 Dec; 129():394-406. PubMed ID: 30315936 [TBL] [Abstract][Full Text] [Related]
16. A novel pyrazolo [3,4-d] pyrimidine, KKC080106, activates the Nrf2 pathway and protects nigral dopaminergic neurons. Lee JA; Kim HR; Son HJ; Shin N; Han SH; Cheong CS; Kim DJ; Hwang O Exp Neurol; 2020 Oct; 332():113387. PubMed ID: 32580013 [TBL] [Abstract][Full Text] [Related]
18. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease. Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397 [TBL] [Abstract][Full Text] [Related]
19. A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP. Son HJ; Lee JA; Shin N; Choi JH; Seo JW; Chi DY; Lee CS; Kim EM; Choe H; Hwang O Br J Pharmacol; 2012 Apr; 165(7):2213-27. PubMed ID: 21951056 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of Nrf2-ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model. Masaki Y; Izumi Y; Matsumura A; Akaike A; Kume T Eur J Pharmacol; 2017 Mar; 798():26-34. PubMed ID: 28167258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]